Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Women with PCOS have higher irisin levels, which may affect their metabolism and hormones.

High testosterone increases heart disease risk in women with PCOS.

Some women with acne have higher levels of free testosterone, which might suggest using hormonal treatments for acne.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Intermittent low-dose finasteride works as well as daily use for treating excessive hair growth in women.

The antiandrogen 11α-hydroxyprogesterone effectively reduces skin oil and cholesterol when applied to the skin.

Low-dose finasteride reduces excessive hair growth in teenage girls safely and affordably.

Married women with type 2 diabetes had a surprisingly low infertility rate, suggesting type 2 diabetes and PCOS may be different conditions.

Men with male pattern baldness may have a higher risk of heart disease due to increased levels of a specific lipid in their blood.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Equilibrium dialysis can accurately measure testosterone levels when lab results are inconsistent.

Adolescent females with PCOS have higher serum cystatin C levels, indicating potential metabolic and cardiovascular issues.

Spironolactone treatment increases the amount of testosterone available in the body.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Hair analysis can somewhat track past testosterone levels but is influenced by factors like hair washing, growth rate, sex, and hair color.

Low doses of mixed chemicals cause permanent reproductive malformations in male rats.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

LLLT is a safe, promising hair loss treatment, but more research needed.

Lower vaspin levels in the blood may indicate a better response to fertility treatment in women with PCOS.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Testosterone changes important cell communication proteins in pregnant rats' uteruses, which might affect pregnancy success.

Low-dose flutamide improved hirsutism and satisfaction in women but had common side effects, causing some to stop treatment.

Sebum production varies by individual and is influenced by age, gender, and hormones, affecting skin and hair health.

Cold temperatures can stop human cell circadian rhythms, but warming restores them.